Ticker LaunchSPAC · Merger completed
Graf Acquisition Corp. IV
Business combination with NKGen Biotech, Inc.
Graf Acquisition Corp. IV is a blank-check company (SPAC) that raised $150M in its initial public offering on May 24, 2021, listing on New York Stock Exchange. It completed its business combination with NKGen Biotech, Inc. on Sep 29, 2023; the combined company is NKGen Biotech, Inc. (NKGN). Dish TV India led the IPO, with Global Eagle Entertainment and Bank of America. White & Case advised the SPAC and Ellenoff Grossman & Schole advised the underwriters on the IPO.
NKGen Biotech is a clinical-stage biotechnology company, incorporated in Delaware and headquartered in Santa Ana, California. It focuses on developing and commercializing autologous, allogeneic and CAR-NK natural killer cell therapeutics.
- Status
- Merger completed
- IPO date
- May 24, 2021
- IPO size
- $150M
- IPO exchange
- New York Stock Exchange
- Target
- NKGen Biotech, Inc. (Legacy NKGen)
- Announced
- Apr 17, 2023
- Closed
- Sep 29, 2023
- Combined company
- NKGen Biotech, Inc. (NKGN)
- IPO underwriters
- Dish TV India, Global Eagle Entertainment, Bank of America and Oppenheimer
- SPAC counsel (IPO)
- White & Case
- Underwriters' counsel (IPO)
- Ellenoff Grossman & Schole
More on this SPAC for subscribers
- Trust balance and value per share
- Redemptions at each extension and at the merger vote
- Liquidation deadline and extension history
- Merger proxy, registration statement and investor presentation
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) May 24, 2021
- Deal announcement (8-K) Apr 17, 2023
- Press release
- All filings on EDGAR CIK 1845459
Other deSPACs that closed in 2023
- Falcon's Beyond Global, Inc.via FAST Acquisition Corp. II · closed Oct 5, 2023
- Cheche Group Inc.via Prime Impact Acquisition I · closed Oct 2, 2023
- Envoy Medical, Inc.via Anzu Special Acquisition Corp I · closed Sep 29, 2023
- Estrella Immunopharma, Inc.via TradeUP Acquisition Corp. · closed Sep 29, 2023
- New Nuvinivia Mercato Partners Acquisition Corp · closed Sep 29, 2023
- Conduit Pharmaceuticals Inc.via Murphy Canyon Acquisition Corp. · closed Sep 22, 2023